Dynavax Technologies Newsroom

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

PR NewswireApr 22 16:00 ET

Why Investors Shouldn't Be Surprised By Dynavax Technologies Corporation's (NASDAQ:DVAX) 25% Share Price Plunge

Simply Wall StApr 20 08:31 ET

Dynavax Technologies Analyst Ratings

BenzingaApr 17 13:34 ET · Ratings

Express News | Dynavax Technologies Corp - Urges Stockholders to Vote 'for' All Four Co's Director Nominees

ReutersApr 17 07:18 ET

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

PR NewswireApr 17 07:15 ET

Goldman Sachs Maintains Dynavax Technologies(DVAX.US) With Sell Rating, Cuts Target Price to $10

Moomoo NewsApr 17 01:31 ET · Ratings

Dynavax, Deep Track Capital Step Up Fight Ahead of June 11 Annual Meeting

MT NewswiresApr 16 12:15 ET

Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.

BenzingaApr 16 09:45 ET

Express News | Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots

BenzingaApr 16 09:45 ET

Express News | Deep Track: Dynavax Technologies' Board Rejects Nomination of Four Candidates to Its Board

ReutersApr 16 08:04 ET

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Yahoo FinanceApr 16 08:00 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Dynavax Technologies (NASDAQ:DVAX) Pulls Back 6.5% This Week, but Still Delivers Shareholders Strong 31% CAGR Over 5 Years

Yahoo FinanceApr 10 08:33 ET

Are Dynavax Technologies Corporation's (NASDAQ:DVAX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall StApr 8 09:44 ET

Express News | Reported Earlier, CenterPoint Energy Moves To Reduce Electric Bills By Up To $2 Monthly By 2027

BenzingaApr 4 03:02 ET

Dynavax Files Preliminary Proxy Statement

PR NewswireApr 3 17:40 ET

Recursion Bolsters Board of Directors With Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

GlobeNewswireMar 18 08:00 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?

Zacks Mar 12 09:05 ET